Molecule is building the first Solana-native DeSci funding platform: Pump.Science
Molecule is building a Solana-native DeSci funding platform: pump.science. Read on for more!
2 min read
Jillian Casalini
DeSci Breaks Ground on Solana
Just like pump.fun is the poster child of Solana’s memecoin bull run, pump.science will be the poster child of Solana’s DeSci movement.
Using bonding curves and a simple UX, pump.fun made launching meme coins (which used to be a somewhat mysterious process) simple, fast, fun, and transparent. Pump.fun showed that when the barriers to creation fall, more good ideas rise, and new users are drawn into crypto. It was proof that culture eats strategy for breakfast.
We are no strangers to bonding curves. Molecule’s founder was yapping about bonding curves funding science back in 2019. Molecule’s newest product, Catalyst, leverages a unique bonding curve for funding early-stage scientific research with IP tokens. But Catalyst is on Ethereum (Base). Solana is faster. And scientific progress must accelerate.
Pump.science: Betting on How to Live Forever
Molecule is developing pump.science, a platform for funding and streaming longevity experiments powered by Wormbot.
On pump.science, anyone can submit or fund experiments with drug regimens for C. elegans worms trying to extend their 20-day lifespan. Every experiment gets a token named after the drug regimen and seeks to answer the question, “Does this regimen extend the worm's lifespan?”
Anyone can buy the drug regimen’s tokens, watch the experiments unfold on Wormbot, and, if the regimen extends the worm’ lifespan, have a stake in the resulting drug development and distribution. The goal? Bet on the winning regimen, get it to humans, and live forever.
This isn’t just fun. It's science.
Learn more about pump.science by joining our Telegram and following us on Twitter.
About Molecule
Molecule is dedicated to advancing scientific research through democratized funding and the tokenization of intellectual property (IP). By transforming IP into liquid, onchain assets, Molecule aligns the incentives of researchers and funders, fostering a more collaborative and efficient research ecosystem.
About the author
Jillian Casalini
I'm a biotech strategist and marketer with a foundation in traditional pharma and a vision for decentralized innovation. My career began in traditional pharma at Eli Lilly, where I learned how large-scale organizations bring rigor, regulation, and reach to life sciences. I also built a strong foundation in go-to-market strategy—bridging science with storytelling and turning complex research into clear, compelling narratives. That experience now fuels my passion for building at the intersection of biotech and decentralized science (DeSci)—where transparency, open collaboration, and new funding models are reshaping how research gets done.
Related Posts
From Token to Shareholder: Molecule's Compliant Path from Community to Equity
The Coin-To-Company Model: Reconciling Decentralized Governance With Securities Regulation Through Structural Separation and Complementary Exemptions Under U.S. Law
